Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clariant AGCLZNF 71 EBITDA Margin % is 16.45% as of Jun. 2026, which is 27% above its 10-year median of 12.94. GuruFocus rates CLZNF with a GF Score™ of 71/100 and a GF Value™ of $9.28 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,579 Chemicals companies, Clariant AG ranks better than 54.53% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Clariant AG's EBITDA for the
six
months ended in Jun. 2026 was $383 Mil. Clariant AG's Revenue for the
six
months ended in Jun. 2026 was $2,326 Mil. Therefore, Clariant AG's EBITDA margin for the quarter that ended in Jun. 2026 was 16.45%.
Clariant AG (OTCPK:CLZNF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Clariant AG EBITDA Margin % Related Terms
Clariant AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Clariant AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLZNF vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Clariant AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariant AG EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Clariant AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Clariant AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariant AG (CLZNF) has a EBITDA Margin % of 16.45% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clariant AG and its competitors. This is 27% above median its historical median of 12.94. Over the past decade, Clariant AG's EBITDA Margin % has ranged from 7.04 to 16.76. According to the industry distribution chart, Clariant AG ranks #718 out of 1579 companies in the Chemicals industry, placing it in the top 45.5%.
Is Clariant AG's EBITDA Margin % too high?
Clariant AG's current EBITDA Margin % of 16.45% is 27% above median its 10-year median of 12.94. Over the past 10 years, this metric has ranged from a low of 7.04 to a high of 16.76. The Chemicals industry median EBITDA Margin % is 9.70. Clariant AG's value of 16.45% is 69.6% above this industry median. Based on the distribution chart, Clariant AG ranks #718 out of 1579 companies in the Chemicals industry, which is above the industry midpoint. Overall, Clariant AG has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clariant AG's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Clariant AG ranks #718 out of 1579 companies for EBITDA Margin %. This puts Clariant AG in the upper half of its industry. The industry median EBITDA Margin % is 9.70. Clariant AG's value of 16.45% is 69.6% above this benchmark. Historically, Clariant AG's own EBITDA Margin % has ranged from 7.04 to 16.76 over the past decade. While the company's 10-year median is 12.94 vs. the industry median of 9.70, Clariant AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.70, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariant AG's current EBITDA Margin % of 16.45% is 69.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clariant AG and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariant AG's current EBITDA Margin % is 16.45%, which is 27% above median its own 10-year median of 12.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariant AG stock overvalued right now?
Based on GuruFocus' analysis, Clariant AG (CLZNF) is currently considered Modestly Undervalued. The stock's GF Value™ is $9.28, compared to a current price of $10.20 — trading 9.9% above its estimated fair value. The current EBITDA Margin % is 16.45%, which is 27% above median its 10-year median of 12.94 and 69.6% above the Chemicals industry median of 9.70. Clariant AG's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Clariant AG (CLZNF), the current EBITDA Margin % is 16.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariant AG (CLZNF) Overvalued in 2026?
Based on GuruFocus' analysis, Clariant AG stock appears to be overvalued.
The current stock price of $10.20 is trading 9.9% above its estimated GF Value™ of $9.28.
GuruFocus considers Clariant AG to be Modestly Undervalued.
Key valuation signals for CLZNF:
EBITDA Margin %: 16.45% (27% above median its 10-year median of 12.94)
GF Value™: $9.28 vs. price of $10.20 (9.9% above fair value)
Industry Position: 69.6% above the Chemicals median (#718 of 1579)
No single metric tells the full story. See the CLZNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. It develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers' manufacturing and treatment processes or add value to their end products. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant's coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
71GF Score
Get the complete analysis for CLZNF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLZNF has been successfully added to your 
